Carmen Vidales-De - Publications

Impact of image-guided radiation therapy with intraprostatic seeds on long-term toxicity in prostate cancer patients undergoing risk-adapted intensification therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 11, 2025

Risk-adapted intensification therapy in high-risk prostate cancer: how relevant is the role of radiation dose.

Journal: Radiation oncology (London, England)

Published: April 16, 2025

MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial.

Journal: The British journal of radiology

Published: September 20, 2021

Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 15, 2021

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.

Journal: Radiation oncology (London, England)

Published: February 12, 2020

Positive prostate biopsy following radiotherapy can predict metastasis-free survival in localized prostate cancer.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: May 28, 2019

Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer.

Journal: Urology

Published: May 02, 2018

Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 07, 2017

Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 26, 2016

Predictive value of PAK6 and PSMB4 expression in patients with localized prostate cancer treated with dose-escalation radiation therapy and androgen deprivation therapy.

Journal: Urologic oncology

Published: February 26, 2014

Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.

Journal: Urology

Published: June 29, 2012

Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer

Journal: Archivos espanoles de urologia

Published: February 10, 2012